Frontiers in cardiology: Alpha blockade and coronary heart disease risk reduction. Symposium, Washington, D.C., September 16, 1986.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012306:Risk
D000317:Adrenergic alpha-Antagonists